ZA85910B - A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form - Google Patents

A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form

Info

Publication number
ZA85910B
ZA85910B ZA85910A ZA85910A ZA85910B ZA 85910 B ZA85910 B ZA 85910B ZA 85910 A ZA85910 A ZA 85910A ZA 85910 A ZA85910 A ZA 85910A ZA 85910 B ZA85910 B ZA 85910B
Authority
ZA
South Africa
Prior art keywords
crystalline
novel
stable
preparation
prazosin hydrochloride
Prior art date
Application number
ZA85910A
Other languages
English (en)
Inventor
Stig Olof Engelbert
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ZA85910B publication Critical patent/ZA85910B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA85910A 1984-06-25 1985-02-06 A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form ZA85910B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI842544A FI79107C (fi) 1984-06-25 1984-06-25 Foerfarande foer framstaellning av stabil -form av prazosinhydroklorid.

Publications (1)

Publication Number Publication Date
ZA85910B true ZA85910B (en) 1985-09-25

Family

ID=8519293

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA85910A ZA85910B (en) 1984-06-25 1985-02-06 A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form

Country Status (17)

Country Link
US (2) US4739055A (enExample)
JP (1) JPS6115881A (enExample)
AT (1) AT389117B (enExample)
AU (1) AU566814B2 (enExample)
BE (1) BE900925A (enExample)
CH (1) CH661045A5 (enExample)
DE (1) DE3429415A1 (enExample)
FI (1) FI79107C (enExample)
FR (1) FR2567124B1 (enExample)
GB (1) GB2160861B (enExample)
IL (1) IL73267A (enExample)
IT (1) IT1224142B (enExample)
LU (1) LU85616A1 (enExample)
NL (1) NL8403250A (enExample)
NZ (1) NZ209962A (enExample)
PT (1) PT79411B (enExample)
ZA (1) ZA85910B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE72244T1 (de) * 1986-03-21 1992-02-15 Heumann Pharma Gmbh & Co Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
JP2756846B2 (ja) * 1989-12-28 1998-05-25 住化ファインケム株式会社 無水のε型結晶体２―〔４―（２―フロイル）ピペラジン―１―イル〕―４―アミノ―６，７―ジメトキシキナゾリン塩酸塩及びその製造方法
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
SK286975B6 (sk) * 2001-02-24 2009-08-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xantínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
BRPI0711558A2 (pt) 2006-05-04 2011-11-08 Boeringer Ingelheim Internat Gmbh polimorfos
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
CA2696579C (en) * 2007-08-17 2017-01-24 Boehringer Ingelheim International Gmbh Purine derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
NZ604091A (en) * 2008-08-15 2014-08-29 Boehringer Ingelheim Int Purin derivatives for use in the treatment of fab-related diseases
BRPI0919288A2 (pt) 2008-09-10 2015-12-15 Boehring Ingelheim Internat Gmbh teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
PH12012501037A1 (en) 2009-11-27 2013-01-14 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
CA2797310C (en) 2010-05-05 2020-03-31 Boehringer Ingelheim International Gmbh Glp-1 receptor agonist and dpp-4 inhibitor combination therapy
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
ES2713566T3 (es) 2011-07-15 2019-05-22 Boehringer Ingelheim Int Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP4151218A1 (en) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Medical use of a dpp-4 inhibitor
WO2017211979A1 (en) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinations of linagliptin and metformin

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2969375A (en) * 1961-01-24 Certification of correction
DE156532C (enExample) *
BE427505A (enExample) * 1937-05-25
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3433788A (en) * 1966-04-27 1969-03-18 Union Carbide Corp Process for recovery of amines from aqueous solutions by solvent treatment and distillation
US3421983A (en) * 1967-03-07 1969-01-14 Lummus Co Azeotropic distillation of aqueous toluene diamine
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3743672A (en) * 1970-05-27 1973-07-03 Halcon International Inc Separation of water in alkylene glycol mono and diester purification by azeotropic distillation
GB1308718A (en) * 1970-07-01 1973-03-07 Sir Soc Italiana Resine Spa Method of separating vinyl acetate from liquid mixtures
IT956765B (it) * 1972-06-22 1973-10-10 Montedison Spa Procedimento per la purificazione di 1 3 diossolano
US3935213A (en) * 1973-12-05 1976-01-27 Pfizer Inc. Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4092315A (en) * 1976-03-01 1978-05-30 Pfizer Inc. Novel crystalline forms of prazosin hydrochloride
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
FI64367C (fi) * 1980-02-26 1986-08-05 Orion Yhtymae Oy Foerfarande foer framstaellning av alfa-form av prazosinhydroklorid

Also Published As

Publication number Publication date
GB2160861B (en) 1987-11-18
FI79107C (fi) 1989-11-10
NZ209962A (en) 1987-06-30
LU85616A1 (fr) 1985-06-04
US4739055A (en) 1988-04-19
CH661045A5 (de) 1987-06-30
IT1224142B (it) 1990-09-26
FI842544A0 (fi) 1984-06-25
JPH0481993B2 (enExample) 1992-12-25
PT79411B (en) 1986-09-15
ATA344184A (de) 1989-03-15
FR2567124B1 (fr) 1990-09-21
IL73267A (en) 1988-06-30
FI842544L (fi) 1985-12-26
AU3451084A (en) 1986-01-02
DE3429415C2 (enExample) 1990-05-03
US4873330A (en) 1989-10-10
FI79107B (fi) 1989-07-31
AU566814B2 (en) 1987-10-29
GB2160861A (en) 1986-01-02
AT389117B (de) 1989-10-25
NL8403250A (nl) 1986-01-16
IT8423292A0 (it) 1984-10-24
IL73267A0 (en) 1985-01-31
PT79411A (en) 1984-11-01
FR2567124A1 (fr) 1986-01-10
BE900925A (fr) 1985-02-15
DE3429415A1 (de) 1986-01-02
GB8424999D0 (en) 1984-11-07
JPS6115881A (ja) 1986-01-23

Similar Documents

Publication Publication Date Title
ZA85910B (en) A novel anhydrous,stable,crystalline o-form of prazosin hydrochloride and a novel process for the preparation of said crystalline o-form
HUT38361A (en) Process for preparing new crystalline modifications
HUT44257A (en) Process for preparing crystalline cefalosporinhydrate
YU191188A (en) Process for preparing new ammonia compounds
PT79963A (en) Process for the preparation of asymetric diesthers
PT81463A (en) Process for preparing novel 5-amino-4-hidroxyvalerylderivatives
CY1565A (en) Novel pleuromutilin derivatives,process for their production and their use
HUT36805A (en) Process for preparing 1-cyclopropyl-quinoline- and -naphthyridine-carboxylic acid derivatives
YU228688A (en) Process for preparing new ammonia compounds
EP0164786A3 (en) A process for the preparation of p-isononanoyloxybenzenenesulphonate
GB2167066B (en) Process for producing urea
PT81522A (en) Process for preparing basic v1-vasopressin antagonists
ZW19887A1 (en) Process for preparing urea
DE3665875D1 (en) Crystalline polyester-imides, process for production thereof, and use thereof
CS690485A2 (en) Process for preparing aminoalcohols
PT81510A (en) Process for preparing v1-vasopressin antagonists
PT85372A (en) Bisucaderin a process for producing this compound and its use as a medicament
YU45030B (en) Process for preparing crystalline cimetidine
IL84403A (en) Process for the preparation of a nitrobenzoylalkane-sulfonamide
HUT42050A (en) Process for preparing 2-choloro-propionic acid
HUT36800A (en) Process for preparing carbamidic acid derivatives
DE3561057D1 (en) Process for preparing 1-naphthyl amine
DE3564274D1 (en) Novel ethyl benzylphosphinate derivatives, process for production thereof, and their use as calcium antagonist
HUT46594A (en) Process for producing ammonia
EP0253360A3 (en) Process for preparing nitriles